GZMK

gene product
PRSS, TRYP2
This gene product is a member of a group of related serine proteases from the cytoplasmic granules of cytotoxic lymphocytes. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here lacks consensus sequences for N-glycosylation present in other granzymes. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
264 antibodies from 27 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
102 antibodies
Aviva Systems Biology
3 antibodies
LifeSpan BioSciences, Inc.
51 antibodies
OriGene
6 antibodies
Affinity Biosciences
1 antibody
Atlas Antibodies
1 antibody
GeneTex
1 antibody
Aldevron
3 antibodies
Bioworld Technology, Inc
1 antibody
Acris Antibodies GmbH
4 antibodies
Invitrogen Antibodies
8 antibodies
Novus Biologicals
4 antibodies
Biorbyt
16 antibodies
BioLegend
14 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
MyBioSource
7 antibodies
Abnova Corporation
4 antibodies
United States Biological
13 antibodies
St John's Laboratory
2 antibodies
Boster Biological Technology
1 antibody
ProSci
1 antibody
Creative Biolabs
2 antibodies
Abbexa
3 antibodies
Creative Diagnostics
1 antibody
GenWay
1 antibody
Sigma-Aldrich
1 antibody